BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 31816923)

  • 21. Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.
    Tsang FH; Au V; Lu WJ; Shek FH; Liu AM; Luk JM; Fan ST; Poon RT; Lee NP
    Dig Dis Sci; 2014 Oct; 59(10):2477-87. PubMed ID: 24811246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p.
    Han S; Xue L; Wei Y; Yong T; Jia W; Qi Y; Luo Y; Liang J; Wen J; Bie N; Liang H; Liu Q; Ding Z; Yang X; Gan L; Huang Z; Chen X; Zhang B
    Adv Sci (Weinh); 2023 Jun; 10(17):e2207080. PubMed ID: 37096833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
    Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
    Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
    [No Abstract]   [Full Text] [Related]  

  • 26. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M; Li M; Wang T; Linghu E; Wu B
    Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters.
    Zhou HC; Fang JH; Shang LR; Zhang ZJ; Sang Y; Xu L; Yuan Y; Chen MS; Zheng L; Zhang Y; Zhuang SM
    J Pathol; 2016 Dec; 240(4):450-460. PubMed ID: 27577856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells.
    Salah RA; Nasr MA; El-Derby AM; Abd Elkodous M; Mohamed RH; El-Ekiaby N; Osama A; Elshenawy SE; Hamad MHM; Magdeldin S; Gabr MM; Abdelaziz AI; El-Badri NS
    Life Sci; 2022 Jan; 288():120168. PubMed ID: 34826437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles.
    Cabiati M; Salvadori C; Basta G; Del Turco S; Aretini P; Cecchettini A; Del Ry S
    Clin Exp Med; 2022 May; 22(2):245-255. PubMed ID: 34319456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
    Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
    J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicle-carried microRNA-27b derived from mesenchymal stem cells accelerates cutaneous wound healing via E3 ubiquitin ligase ITCH.
    Cheng S; Xi Z; Chen G; Liu K; Ma R; Zhou C
    J Cell Mol Med; 2020 Oct; 24(19):11254-11271. PubMed ID: 32845084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of miRNA Reference Genes in Extracellular Vesicles from Adipose Derived Mesenchymal Stem Cells for Studying Osteoarthritis.
    Ragni E; Perucca Orfei C; De Luca P; Colombini A; ViganĂ² M; Lugano G; Bollati V; de Girolamo L
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
    Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
    Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.
    Nguyen MA; Karunakaran D; Geoffrion M; Cheng HS; Tandoc K; Perisic Matic L; Hedin U; Maegdefessel L; Fish JE; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):49-63. PubMed ID: 28882869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma.
    Wang F; Li L; Piontek K; Sakaguchi M; Selaru FM
    Hepatology; 2018 Mar; 67(3):940-954. PubMed ID: 29023935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.